92
Views
3
CrossRef citations to date
0
Altmetric
Original Research

The Clinical Effects of Febuxostat Alone or Combined with Arthroscopic Surgery for Gout: A Single-Center Retrospective Study

, , , , , , , , ORCID Icon & show all
Pages 4509-4517 | Published online: 07 Sep 2021

References

  • Dalbeth N, Gosling AL, Gaffo A, et al. Gout. Lancet. 2021;397(10287):1843–1855. doi:10.1016/S0140-6736(21)00569-9
  • Richette P, Bardin T. Gout. Lancet. 2010;375(9711):318–328. doi:10.1016/S0140-6736(09)60883-7
  • Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016;388(10055):2039–2052. doi:10.1016/S0140-6736(16)00346-9
  • Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med. 2005;143(7):499–516. doi:10.7326/0003-4819-143-7-200510040-00009
  • Ruoff G, Edwards NL. Overview of serum uric acid treatment targets in gout: why less than 6 mg/dL? Postgrad Med. 2016;128(7):706–715. doi:10.1080/00325481.2016.1221732
  • Singh JV, Bedi P, Singh H, et al. Xanthine oxidase inhibitors: patent landscape and clinical development (2015–2020). Expert Opin Ther Pat. 2020;30(10):769–780. doi:10.1080/13543776.2020.1811233
  • Kumar R, Darpan SS, Sharma S, et al. Xanthine oxidase inhibitors: a patent survey. Expert Opin Ther Pat. 2011;21(7):1071–1108. doi:10.1517/13543776.2011.577417
  • Ojha R, Singh J, Ojha A, et al. An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011–2015). Expert Opin Ther Pat. 2017;27(3):311–345. doi:10.1080/13543776.2017.1261111
  • Mackenzie IS, Ford I, Nuki G, et al. Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial. Lancet. 2020;396(10264):1745–1757. doi:10.1016/S0140-6736(20)32234-0
  • Fitzgerald JD, Dalbeth N, Mikuls T, et al. American college of rheumatology guideline for the management of gout. Arthritis Rheumatol. 2020;72(6):879–895. doi:10.1002/art.41247
  • Rheumatology Branch of Chinese Medical Association. China gout clinical practice guideline. Zhonghua Nei Ke Za Zhi. 2016;55(11):892–899.
  • Carcione J, Bodofsky S, LaMoreaux B, et al. Beyond medical treatment: surgical treatment of gout. Curr Rheumatol Rep. 2020;23(1):1. doi:10.1007/s11926-020-00969-6
  • Steinmetz RG, Maxted M, Rowles D. Arthroscopic management of intra-articular tophaceous gout of the knee: a case report and review of the literature. J Orthop Case Rep. 2018;8(2):86–89.
  • Aoki T, Tensho K, Shimodaira H, et al. Intrameniscal gouty tophi in the knee: a case report. JBJS Case Connect. 2015;5(3):e74. doi:10.2106/JBJS.CC.N.00191
  • Li HL, Li SY, Li CB, et al. Clinical observation of arthroscopic debridement for acute gouty arthritis of the ankle. Zhongguo Gu Shang. 2016;29(3):258–260.
  • Pan F, Li Q, Tang X, et al. Method and effectiveness of arthroscopic debridement for treating gouty arthritis of the knee. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2011;25(8):937–940.
  • Neogi T, Jansen TL, Dalbeth N, et al. Gout classification criteria: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheumatol. 2015;67(10):2557–2568. doi:10.1002/art.39254
  • Neogi T. Gout. Ann Intern Med. 2016;165(1):ITC1–16. doi:10.7326/AITC201607050
  • Lamers-Karnebeek FB, Van Riel PL, Jansen TL. Additive value for ultrasonographic signal in a screening algorithm for patients presenting with acute mono-/oligoarthritis in whom gout is suspected. Clin Rheumatol. 2014;33(4):555–559. doi:10.1007/s10067-014-2505-6
  • Wilson L, Saseen JJ. Gouty arthritis: a review of acute management and prevention. Pharmacotherapy. 2016;36(8):906–922. doi:10.1002/phar.1788
  • Pascual E, Andres M, Vazquez-Mellado J, et al. Severe gout: strategies and innovations for effective management. Joint Bone Spine. 2017;84(5):541–546. doi:10.1016/j.jbspin.2016.10.004
  • Miao Z, Li C, Chen Y, et al. Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol. 2008;35(9):1859–1864.
  • Gao Q, Cheng X, Merriman TR, et al. Trends in the manifestations of 9754 gout patients in a Chinese clinical center: a 10-year observational study. Joint Bone Spine. 2020:105078. doi:10.1016/j.jbspin.2020.09.010
  • Dalbeth N, Saag KG, Palmer WE, et al. Effects of febuxostat in early gout: a randomized, double-blind, placebo-controlled study. Arthritis Rheumatol. 2017;69(12):2386–2395. doi:10.1002/art.40233
  • Sun R, Lu J, Li H, et al. Evaluation of febuxostat initiation during an acute gout attack: a prospective, randomized clinical trial. Joint Bone Spine. 2020;87(5):461–466. doi:10.1016/j.jbspin.2020.03.017
  • Desai J, Steiger S, Anders HJ. Molecular pathophysiology of gout. Trends Mol Med. 2017;23(8):756–768. doi:10.1016/j.molmed.2017.06.005